Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ONCR

Oncorus (ONCR)

Oncorus Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONCR
DateTimeSourceHeadlineSymbolCompany
12/22/20226:02AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ONCROncorus Inc
12/15/20226:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
11/30/20227:00AMGlobeNewswire Inc.Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with CancerNASDAQ:ONCROncorus Inc
11/23/20228:00AMGlobeNewswire Inc.Oncorus to Participate in Upcoming Investor ConferencesNASDAQ:ONCROncorus Inc
11/18/20228:00AMGlobeNewswire Inc.Oncorus Presents Preclinical Data Supporting ONCR-719, an armed HSV-1 Vector engineered to use the Epidermal Growth Factor Receptor (EGFR/EGFRvIII) for viral entry in Glioblastoma, at the 2022 Society for Neuro-Oncology Annual MeetingNASDAQ:ONCROncorus Inc
11/07/20226:15AMTipRanksOncorus (ONCR) Gets a Buy from H.C. WainwrightNASDAQ:ONCROncorus Inc
11/02/20224:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
11/02/20224:32PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ONCROncorus Inc
11/02/20227:12AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
11/02/20227:00AMGlobeNewswire Inc.Oncorus Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
11/01/20224:07PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ONCROncorus Inc
10/07/20229:00AMGlobeNewswire Inc.Oncorus Announces Publication in Nature Communications Highlighting the Development of its Intravenously Administered Synthetic vRNA/LNP Platform for the Treatment of CancerNASDAQ:ONCROncorus Inc
09/26/20227:00AMGlobeNewswire Inc.Oncorus to Present at Chardan’s 6th Annual Genetic Medicines ConferenceNASDAQ:ONCROncorus Inc
09/14/20224:36PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
09/06/20227:00AMGlobeNewswire Inc.Oncorus to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:ONCROncorus Inc
08/15/20226:15AMTipRanksH.C. Wainwright Sticks to Its Buy Rating for Oncorus (ONCR)NASDAQ:ONCROncorus Inc
08/04/20229:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
08/04/20227:00AMGlobeNewswire Inc.Oncorus Reports Second Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
07/08/20224:58PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ONCROncorus Inc
06/23/20227:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
06/23/20227:00AMGlobeNewswire Inc.Oncorus Appoints Douglas Fambrough to Board of DirectorsNASDAQ:ONCROncorus Inc
06/01/20227:00AMGlobeNewswire Inc.Oncorus to Present at the Jefferies Global Healthcare ConferenceNASDAQ:ONCROncorus Inc
05/25/20224:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
05/24/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
05/19/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
05/17/20227:00AMGlobeNewswire Inc.Oncorus to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:ONCROncorus Inc
05/16/20226:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
05/12/20224:51PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ONCROncorus Inc
05/10/20227:10AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
05/10/20227:00AMGlobeNewswire Inc.Oncorus Announces Appointment of Richard Wanstall as Chief Financial OfficerNASDAQ:ONCROncorus Inc
 Showing the most relevant articles for your search:NASDAQ:ONCR